The Third People's Hospital of Hubei Province
9
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
22%
2 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Tirofiban After Successful MT Recanalization in AIS
Role: collaborator
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
Role: collaborator
Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial
Role: collaborator
Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification
Role: collaborator
Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
Role: collaborator
The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis
Role: collaborator
Xingnaojing for Mild-to-severe Acute Ischemic Stroke
Role: collaborator
Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
Role: collaborator
Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
Role: collaborator
All 9 trials loaded